Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
You leave off one category of optimist. Those who simply and for obvious reasons have abandoned posting to this ihub board.
NNVC has been very disappointing. Many still believe in the potential for Viricides. Some can/will not be able to leave investment capital idle for an additional 2-3 years. Others will hold.
As it ever was. So true, so true.
"The lady doth protest too much, methinks."
Shakespeare
Thanks for posting.
Who indeed.
Thanks. Yes, I'd read this PR. It's good to see progress in the pipeline.
You're going to need a deep supply of "" marks. I don't anticipate a true come back for quite some time. The lab must be certified. Upscale must be accomplished. Sufficient materials for resumption of Toxicity testing must be produced. BASi results, positive results, must be achieved. Should I go on? The list above is only the beginning.
Nanoviricides has promise. Fulfillment of the promise remains well in the future, if at all. (Diwan's vision is compelling. Hell, that's why I'm in. But the science must be proven and the practicality of converting that science into dependable, repeatable, profit making workflow must be proven.)
A few pennies gained here and there does not constitute a come back and won't counter our extended downward trend. Milestones must be achieved and recognized by the market. Nanoviricides' big investors are playing the long game. Only those who have patience and the luxury of keeping capital on the sidelines will benefit from this undertaking.
GLTA Longs.
Nice recap. Thanks.
Well written. Painful. As a long this stretch has not been fun and your posts often contribute to the discomfort. Still, I read all your posts and appreciate your observations. Thanks. (Damn that CB.)
"Nothing" is for free. Therefore...you got your free prize.
Hear, hear!
Possible.
The presentation was positive with detailed information that reinforced the story of an upward revenue trend that has been discussed on this board. Q&A was lively.
A link to the presentation can be found on IEVM's corporate site.
They're trending toward profitability. If they can maintain or accelerate the pace shareholder value will track favorably.
IEVM has additional revenue opportunity in healthcare industry and food service. There's potential for growth and potential other well established competitors might see IEVM as an attractive acquisition.
Trading in the millions may be a ways off. The last two days of trading have been very interesting and positive. I suspect good news is on the way. Hopefully next week.
The market seems to disagree. (Today). Substantial volume, overwhelmingly positive action. Many seem to believe buying at .07 was a good idea. (It's a volatile stock. The opportunity may return tomorrow.)
$400,000 annual salary? You have to set I higher benchmark if you're hoping to drum up outrage.
Nanoviricides was also circumspect regarding their partner in this effort. One might imply that USAMRIID has requested NNVC be extremely cautious not to exploit the combined efforts until final results are interpreted and can be released. Perhaps jointly. Until it is announced that testing has ended I'm going to remain optimistic.
GLTA longs.
Thanks Rearden.
What is the context of your statement?
Thank you. Your's is a point of view that I'm confident resonates with many long time holders.
Quote source: Dune
IEVM is on simmer.
It counts for FDA approval, I completely agree. It must be completed.
It is not necessary for my approval as an investor.
I accept the veracity of internal tests, Kard preliminary tests and the first results from BASi. Those preliminary results meet my requirement to keep my money in NNVC. For that standard I do not need to prove it to you or the FDA.
Viricides are non-toxic. Attach whatever acronym you wish to the studies completed to date. The results will prove their value and contribute to human trials.
Viricides have been demonstrated very effective against certain viruses. Deride the studies completed to date for their lack of peer review or the fact that NNVC has not directed all energies toward cure for a single viral disease but the results will contribute to the formulation of a definitive anti-viral cure.
If you are a long the breadcrumb trail is sufficient, perhaps frustrating to follow at times, but sufficient to support your commitment year after year.
If you bought high and sold low I understand your anger but that's the kind of high risk investment we're participating in with NNVC.
Too many of the negative posts to this board are, intended or not, hurtful to shareholders and supporters. The criticism is misdirected.
Bullshit- (FAWUN# 2)
Thanks LoanRanger.
I've checked with a few of my friends on MySpace and that kind of technology leapfrogging just doesn't happen. If you need details give me a number and I'll fax the proof. Gotta go, The Western Union guy is at the door.
I can't disagree with the employee counts, as reported. Still, someone must be manufacturing and delivering the product. Contractors? The growth of actively supported well sites is encouraging. Also, the ROI associated with new depots is fast which will support speedy expansion. 2016 may see profitability. A strong trend toward profitability may mean share price increases in anticipation of profitability. I've got a position staked out, I'm holding.
I wonder how our little bots are doing in their battle against Ebola. Go EbolaCide2!
GLTA longs.
Thanks.
I'm bullish in the long term. Revenue may not satisfy Mr. Market in early 2015 but I believe net profits will be strong going forward into 2016. I see value in this stock.
It certainly was. I've achieved my desired position. Let 'er run from this point on.
There have been multiple external validations throughout the years. Supporters accept them, detractors reject them.
USAMRIID EbolaCide2 testing will be out this spring.
GLTA longs.
I'd love to get a point of view on yesterday's announcement from a respected analyst or financial publication. If any come across an article please post the link.
TIA.
The days of accumulating in the .50s may be gone. I may have to adjust. Damn difficult for a cheap ba*t@rd like myself. Too capable measuring cost, too incapable of envisioning pay out.
GLTA longs.
Okay, that's funny. I must admit.
GLTA longs. Happy Friday.
Loan Ranger,
Thanks again. The first part of your explanation presented a new concept for me. Your explanation was very clear. Part two I understood but could never have articulated it in such succinct fashion.
Your contributions to my understanding of complicated financial and regulatory matters, both public and via PM, are deeply appreciated.
Crashco
A shout out to USAMRIID; ",Keep sticking those mice.”
GLTA longs.
Thanks for revisiting this question. And thanks for your PM. I'm limited to a single daily post on that other board so I'm taking the opportunity here to voice my appreciation.
Keep up the good work. You are a great source.
Thanks for highlighting. Adjustments seem rather benign.
I'm curious to hear LoanRanger's point of view. LR's contribution to matters of fiscal reporting are always educational.